Grantham, Mayo, Van Otterloo & Co (GMO)
QDEL icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s QuidelOrtho QDEL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,200
Closed -$311K – 777
2022
Q2 		$311K Buy
+3,200
New +$326K ﹤0.01% 665

Other funds holding QDEL

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s QDEL Position: Q3 2022 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of QuidelOrtho (QDEL) in Q3 2022, closing a stake of 3,200 shares — an estimated $311K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in QDEL in Q2 2022 and held it in 1 quarter. The position peaked at $311K in Q2 2022. 315 funds tracked by Wall St. Rank hold QDEL as of Q3 2022.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining QuidelOrtho position as of Q3 2022 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,200 QuidelOrtho shares in Q3 2022, an estimated $311K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in QuidelOrtho in Q2 2022 and held it in 1 quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s QuidelOrtho position peaked at $311K in Q2 2022.
  • 315 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2022.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.